Dean M Scholl

Avidbiotics Corporation

$3,224,757

Attributed

$3,224,757

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $530.3K · FY2009–20

$1M$750K$500K$250K$0

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NIH$3,224,757 · 4

By mechanism

R33$1,464,241 · 1

R43$943,669 · 1

R21$816,847 · 2

Top collaborators

No co-investigators on record.

Most similar at Avidbiotics Corporation

Same institution · by research overlap

David William Martin$3,596,583

Others in their field

Top investigators on “Bacteriophages”

Henry F Chambers · Duke University$46,515,637
Vance G Fowler · Duke University$46,515,637
Venigalla B. Rao · Brookhaven Science Assoc-Brookhaven Lab$16,506,652
John J Mekalanos · Harvard Medical School$16,465,337
Smita S Patel · Univ Of Med/Dent Nj-R W Johnson Med Sch$15,831,215
Stanley J Opella · Wistar Institute$14,038,188

Research focus

BacteriophagesCessation Of LifeTailFiberReceptor BindingPublic Health RelevanceEngineeringPathogenInfectionProphylacticProteinsProtein ComplexAnimal ModelBacteriaBacterial InfectionsBactericideBacteriocinProductionAntibioticsDoseAnimalsKillingsLibrariesStructure